AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2020
May 16, 2020
32853_dirs_2020-05-15_97d75fd9-529b-4469-a047-e9a91c213987.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-05-05
Reporting Person: Khadder Nicholas (SVP, Gen. Counsel & Secretary)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50668 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $6.33 | 2020-06-11 | Common Stock (13179.0) | Direct | |
| Employee Stock Option (Right to Buy) | $5.13 | 2020-06-11 | Common Stock (52607.0) | Direct |
Footnotes
F1: The option became exerciseable as to 6,876 shares on 3/19/2019 and as to an additional 573 shares each month thereafter through 2/19/20.
F2: The option became exerciseable as to 5,845 shares on 2/20/2018 and as to approximately 5,845 additional shares each quarter thereafter through 2/20/20.
More from STANDARD BIOTOOLS INC.
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5